Aimei Health Technology (AFJK) Competitors $11.03 0.00 (0.00%) As of 05/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AFJK vs. BIOX, SJT, CEPO, SBXD, RENE, BZAI, NREF, TCI, PINE, and UROYShould you be buying Aimei Health Technology stock or one of its competitors? The main competitors of Aimei Health Technology include Bioceres Crop Solutions (BIOX), San Juan Basin Royalty Trust (SJT), Cantor Equity Partners I (CEPO), Silverbox Corp IV (SBXD), Cartesian Growth Co. II (RENE), Blaize (BZAI), NexPoint Real Estate Finance (NREF), Transcontinental Realty Investors (TCI), Alpine Income Property Trust (PINE), and Uranium Royalty (UROY). These companies are all part of the "trading" industry. Aimei Health Technology vs. Bioceres Crop Solutions San Juan Basin Royalty Trust Cantor Equity Partners I Silverbox Corp IV Cartesian Growth Co. II Blaize NexPoint Real Estate Finance Transcontinental Realty Investors Alpine Income Property Trust Uranium Royalty Bioceres Crop Solutions (NASDAQ:BIOX) and Aimei Health Technology (NASDAQ:AFJK) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, community ranking, media sentiment, risk, profitability, analyst recommendations and dividends. Does the media prefer BIOX or AFJK? In the previous week, Bioceres Crop Solutions and Bioceres Crop Solutions both had 3 articles in the media. Aimei Health Technology's average media sentiment score of 1.76 beat Bioceres Crop Solutions' score of 1.02 indicating that Aimei Health Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bioceres Crop Solutions 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aimei Health Technology 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has more risk & volatility, BIOX or AFJK? Bioceres Crop Solutions has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500. Comparatively, Aimei Health Technology has a beta of -0.04, indicating that its stock price is 104% less volatile than the S&P 500. Which has stronger earnings & valuation, BIOX or AFJK? Bioceres Crop Solutions has higher revenue and earnings than Aimei Health Technology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioceres Crop Solutions$407.73M0.67$3.24M$0.02218.00Aimei Health TechnologyN/AN/A$170KN/AN/A Do insiders and institutionals believe in BIOX or AFJK? 17.7% of Bioceres Crop Solutions shares are held by institutional investors. Comparatively, 45.6% of Aimei Health Technology shares are held by institutional investors. 2.3% of Bioceres Crop Solutions shares are held by insiders. Comparatively, 1.7% of Aimei Health Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community prefer BIOX or AFJK? Bioceres Crop Solutions received 34 more outperform votes than Aimei Health Technology when rated by MarketBeat users. CompanyUnderperformOutperformBioceres Crop SolutionsOutperform Votes3479.07% Underperform Votes920.93% Aimei Health TechnologyN/AN/A Do analysts rate BIOX or AFJK? Bioceres Crop Solutions presently has a consensus target price of $8.63, indicating a potential upside of 97.82%. Given Bioceres Crop Solutions' stronger consensus rating and higher possible upside, analysts clearly believe Bioceres Crop Solutions is more favorable than Aimei Health Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bioceres Crop Solutions 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 3.33Aimei Health Technology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is BIOX or AFJK more profitable? Bioceres Crop Solutions has a net margin of 0.58% compared to Aimei Health Technology's net margin of 0.00%. Bioceres Crop Solutions' return on equity of 0.68% beat Aimei Health Technology's return on equity.Company Net Margins Return on Equity Return on Assets Bioceres Crop Solutions0.58% 0.68% 0.28% Aimei Health Technology N/A N/A N/A SummaryBioceres Crop Solutions beats Aimei Health Technology on 12 of the 14 factors compared between the two stocks. Get Aimei Health Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for AFJK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AFJK vs. The Competition Export to ExcelMetricAimei Health TechnologyHolding Offices IndustryFinancial SectorNASDAQ ExchangeMarket Cap$67.34M$473.79M$3.84B$7.93BDividend YieldN/A7.74%4.21%4.22%P/E RatioN/A2.4113.0518.54Price / SalesN/A54.241,692.12103.30Price / Cash500.2069.0150.4934.62Price / Book-550.003.663.414.25Net Income$170,000.00$35.22M$1.25B$248.18M7 Day Performance-0.50%1.56%0.95%1.03%1 Month Performance0.18%4.34%13.41%2.70%1 Year Performance6.80%24.28%12.66%4.05% Aimei Health Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AFJKAimei Health TechnologyN/A$11.03flatN/A+6.8%$67.53MN/A0.00N/ANews CoveragePositive NewsBIOXBioceres Crop Solutions2.8877 of 5 stars$4.28+4.4%$8.63+101.5%-62.6%$268.40M$407.73M214.11500Positive NewsSJTSan Juan Basin Royalty Trust1.0213 of 5 stars$5.75+1.3%N/A+46.3%$267.77M$6.95M21.282,020CEPOCantor Equity Partners IN/A$10.38+0.3%N/AN/A$264.69MN/A0.002SBXDSilverbox Corp IVN/A$10.21-0.1%N/AN/A$259.90MN/A0.00N/AHigh Trading VolumeRENECartesian Growth Co. IIN/A$11.92-0.1%N/A+6.4%$257.61MN/A0.002Short Interest ↑News CoveragePositive NewsBZAIBlaizeN/A$2.47-7.5%$5.83+136.2%N/A$250.93M$1.55M0.00N/ANREFNexPoint Real Estate Finance3.7811 of 5 stars$14.02+2.2%$14.50+3.5%+9.3%$247.28M$29.20M13.351Dividend AnnouncementShort Interest ↓News CoverageTCITranscontinental Realty Investors0.8744 of 5 stars$27.98-0.1%N/A+2.7%$241.68M$44.76M75.61N/AUpcoming EarningsAnalyst ForecastPINEAlpine Income Property Trust3.2219 of 5 stars$16.56+0.7%$19.32+16.7%+3.4%$239.72M$52.23M118.29N/AShort Interest ↑UROYUranium Royalty1.3656 of 5 stars$1.76+5.4%$4.00+127.3%-21.4%$235.20M$23.14M58.6910News Coverage Related Companies and Tools Related Companies BIOX Competitors SJT Competitors CEPO Competitors SBXD Competitors RENE Competitors BZAI Competitors NREF Competitors TCI Competitors PINE Competitors UROY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AFJK) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive red flag about American consumerWhy is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U....Stansberry Research | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aimei Health Technology Co., Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Aimei Health Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.